BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warneke VS, Behrens HM, Hartmann JT, Held H, Becker T, Schwarz NT, Röcken C. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol. 2011;29:2364-2371. [PMID: 21537040 DOI: 10.1200/jco.2010.34.4358] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim SG, Seo HS, Lee HH, Song KY, Park CH. Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea. J Gastric Cancer 2017;17:212-9. [PMID: 28970951 DOI: 10.5230/jgc.2017.17.e23] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
2 Lu J, Zheng ZF, Wang W, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Zhou ZW, Huang CM, Zheng CH, Li P. A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system. Gastric Cancer 2019;22:759-68. [PMID: 30612230 DOI: 10.1007/s10120-018-00904-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
3 Röcken C. [Ways to personalized medicine for gastric cancer]. Pathologe 2013;34:403-12. [PMID: 23907566 DOI: 10.1007/s00292-013-1785-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ishigami S, Arigami T, Uchikado Y, Setoyama T, Kita Y, Sasaki K, Okumura H, Kurahara H, Kijima Y, Harada A. IL-32 expression is an independent prognostic marker for gastric cancer. Med Oncol. 2013;30:472. [PMID: 23479179 DOI: 10.1007/s12032-013-0472-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zeng Z, Xie D, Gong J. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer. PeerJ 2020;8:e9624. [PMID: 32821544 DOI: 10.7717/peerj.9624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Yasumoto M, Sakamoto E, Ogasawara S, Isobe T, Kizaki J, Sumi A, Kusano H, Akiba J, Torimura T, Akagi Y, Itadani H, Kobayashi T, Hasako S, Kumazaki M, Mizuarai S, Oie S, Yano H. Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer. Cancer Med 2017;6:235-44. [PMID: 27891760 DOI: 10.1002/cam4.959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Wang X, He H, Zhang H, Chen W, Ji Y, Tang Z, Fang Y, Wang C, Liu F, Shen Z, Qin J, Zhu Y, Liu H, Xu J, Gu J, Qin X, Sun Y. Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer. Cancer Sci 2013;104:185-93. [PMID: 23107376 DOI: 10.1111/cas.12049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
8 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
9 Reim D, Novotny A, Friess H, Slotta-Huspenina J, Weichert W, Ott K, Dislich B, Lorenzen S, Becker K, Langer R. Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas. J Pathol Clin Res 2020;6:263-72. [PMID: 32401432 DOI: 10.1002/cjp2.169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Huang ZN, Desiderio J, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Lin JL, Zheng HL, Huang CM. Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study. BMC Gastroenterol 2019;19:205. [PMID: 31791240 DOI: 10.1186/s12876-019-1096-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Sawaki A, Ohashi Y, Omuro Y, Satoh T, Hamamoto Y, Boku N, Miyata Y, Takiuchi H, Yamaguchi K, Sasaki Y, Nishina T, Satoh A, Baba E, Tamura T, Abe T, Hatake K, Ohtsu A. Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer 2012;15:313-22. [PMID: 22179434 DOI: 10.1007/s10120-011-0118-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
12 Lin JX, Lin JP, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, Huang CM. New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database. World J Clin Cases 2019; 7(2): 145-155 [PMID: 30705892 DOI: 10.12998/wjcc.v7.i2.145] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Lin JX, Desiderio J, Lin JP, Wang W, Tu RH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Zhou ZW, Parisi A, Huang CM. Multicenter Validation Study of the American Joint Commission on Cancer (8th Edition) for Gastric Cancer: Proposal for a Simplified and Improved TNM Staging System. J Cancer 2020;11:3483-91. [PMID: 32284744 DOI: 10.7150/jca.36891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Warneke VS, Behrens HM, Böger C, Becker T, Lordick F, Ebert MP, Röcken C. Her2/neu testing in gastric cancer: evaluating the risk of sampling errors. Ann Oncol 2013;24:725-33. [PMID: 23139264 DOI: 10.1093/annonc/mds528] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
15 Marano L, D'Ignazio A, Cammillini F, Angotti R, Messina M, Marrelli D, Roviello F. Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: old problems and new perspectives. Transl Gastroenterol Hepatol. 2019;4:22. [PMID: 31143843 DOI: 10.21037/tgh.2019.03.09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
16 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]
17 Tural D, Selçukbiricik F, Serdengeçti S, Büyükünal E. A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients. World J Surg Oncol. 2012;10:234. [PMID: 23121731 DOI: 10.1186/1477-7819-10-234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
18 Böger C, Warneke VS, Behrens HM, Kalthoff H, Goodman SL, Becker T, Röcken C. Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer 2015;18:784-95. [PMID: 25315085 DOI: 10.1007/s10120-014-0435-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
19 Shu P, Qin J, Shen K, Chen W, Liu F, Fang Y, Wang X, Wang H, Shen Z, Sun Y, Qin X. The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III. BMC Cancer 2017;17:238. [PMID: 28359303 DOI: 10.1186/s12885-017-3235-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
20 Deng ZJ, Nie RC, Lu J, Chen XJ, Xiang J, Huang CM, Chen YB, Peng JS, Chen S. Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research. BMC Gastroenterol 2021;21:363. [PMID: 34620108 DOI: 10.1186/s12876-021-01937-9] [Reference Citation Analysis]
21 Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. PLoS One 2016;11:e0149555. [PMID: 26967161 DOI: 10.1371/journal.pone.0149555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
22 Kawasaki Y, Ishigami S, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kita Y, Nishizono Y, Okumura H, Nakajo A, Kijima Y, Maemura K, Natsugoe S. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer. BMC Cancer. 2015;15:5. [PMID: 25588809 DOI: 10.1186/s12885-015-1008-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
23 Zhang J, Zhou Y, Jiang K, Shen Z, Ye Y, Wang S. Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies. Tumour Biol 2014;35:8525-32. [PMID: 24696259 DOI: 10.1007/s13277-014-1848-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
24 He H, Chen W, Wang X, Wang C, Liu F, Shen Z, Xu J, Gu J, Sun Y. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci. 2012;103:1296-1303. [PMID: 22471696 DOI: 10.1111/j.1349-7006.2012.02295.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
25 Sunakawa Y, Lenz HJ. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr Treat Options Oncol. 2015;16:17. [PMID: 25813036 DOI: 10.1007/s11864-015-0331-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
26 Seeruttun SR, Yuan S, Qiu H, Huang Y, Li Y, Liang Y, Guan Y, Zhan Y, Li W, Chen Y, Sun X, Xu D, Zhou Z. A comprehensive analysis comparing the eighth AJCC gastric cancer pathological classification to the seventh, sixth, and fifth editions. Cancer Med 2017;6:2804-13. [PMID: 29105368 DOI: 10.1002/cam4.1230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wu Y, Li Q, Zhou X, Yu J, Mu Y, Munker S, Xu C, Shen Z, Müllenbach R, Liu Y, Li L, Gretz N, Zieker D, Li J, Matsuzaki K, Li Y, Dooley S, Weng H. Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer. PLoS One 2012;7:e35684. [PMID: 22539990 DOI: 10.1371/journal.pone.0035684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, Ichimura T, Ushiku T, Funahashi S, Tateishi K, Wada I, Shimizu N, Nomura S, Koike K, Seto Y, Fukayama M, Aburatani H, Ishikawa S. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 2014;46:583-587. [PMID: 24816255 DOI: 10.1038/ng.2984] [Cited by in Crossref: 305] [Cited by in F6Publishing: 295] [Article Influence: 38.1] [Reference Citation Analysis]
29 Galizia G, Lieto E, Auricchio A, Cardella F, Mabilia A, Diana A, Castellano P, De Vita F, Orditura M. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience. PLoS One 2017;12:e0173619. [PMID: 28380037 DOI: 10.1371/journal.pone.0173619] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
30 Warneke VS, Behrens HM, Haag J, Krüger S, Simon E, Mathiak M, Ebert MP, Röcken C. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis. Br J Cancer. 2013;109:2217-2227. [PMID: 24008668 DOI: 10.1038/bjc.2013.536] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
31 Zhang J, Jiang K, Liu Y, Ye Y, Lv L, Shen Z, Zhou Y, Wang S. Proposal of a new lymph node staging system for gastric cancer: study from two institutions in China. Med Oncol 2014;31:229. [PMID: 25213762 DOI: 10.1007/s12032-014-0229-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Zheng H, Nong Z, Lu G. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression. Med Sci Monit 2015;21:2893-9. [PMID: 26410168 DOI: 10.12659/MSM.894467] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
33 He X, Wu W, Lin Z, Ding Y, Si J, Sun LM. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis. Gastric Cancer 2018;21:391-400. [PMID: 29052053 DOI: 10.1007/s10120-017-0770-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
34 Chen MW, Yen HH. Comparison of the sixth, seventh, and eighth editions of the American Joint Committee on Cancer Tumor-Node-Metastasis staging system for gastric cancer: A single institution experience. Medicine (Baltimore) 2021;100:e27358. [PMID: 34596145 DOI: 10.1097/MD.0000000000027358] [Reference Citation Analysis]
35 Hong SA, Son MW, Cho J, Lee CH, Jang SH, Lee HJ, Lee JH, Cho HD, Oh MH, Lee KT, Lee MS. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer. Medicine (Baltimore) 2018;97:e9703. [PMID: 29505025 DOI: 10.1097/MD.0000000000009703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lu J, Zheng CH, Cao LL, Ling SW, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Huang CM. Validation of the American Joint Commission on Cancer (8th edition) changes for patients with stage III gastric cancer: survival analysis of a large series from a Specialized Eastern Center. Cancer Med 2017;6:2179-87. [PMID: 28913982 DOI: 10.1002/cam4.1118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
37 Lin X, Zhao Y, Song WM, Zhang B. Molecular classification and prediction in gastric cancer. Comput Struct Biotechnol J 2015;13:448-58. [PMID: 26380657 DOI: 10.1016/j.csbj.2015.08.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
38 Peng CW, Wang LW, Fang M, Yang GF, Li Y, Pang DW. Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer. J Transl Med 2013;11:153. [PMID: 23787075 DOI: 10.1186/1479-5876-11-153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
39 Oh SJ, Suh BJ, Park JK, Oh SD, Yu HJ. Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection. Case Rep Oncol 2017;10:57-65. [PMID: 28203165 DOI: 10.1159/000455189] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction. Diagn Pathol. 2014;9:125. [PMID: 25029906 DOI: 10.1186/1746-1596-9-125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
41 Deng J, Zhang R, Zhang L, Liu Y, Hao X, Liang H. Negative node count improvement prognostic prediction of the seventh edition of the TNM classification for gastric cancer. PLoS One. 2013;8:e80082. [PMID: 24348906 DOI: 10.1371/journal.pone.0080082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
42 Marano L, Boccardi V, Braccio B, Esposito G, Grassia M, Petrillo M, Pezzella M, Porfidia R, Reda G, Romano A, Schettino M, Cosenza A, Izzo G, Di Martino N. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study. World J Surg Oncol 2015;13:215. [PMID: 26179492 DOI: 10.1186/s12957-015-0633-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
43 Su Y, Lin Y, Zhang L, Liu B, Yuan W, Mo X, Wang X, Li H, Xing X, Cheng X, Dong B, Hu Y, Du H, Zhu Y, Ding N, Li J, Liu W, Ma Y, Qiu X, Ji J, Han W. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer. Cancer Sci 2014;105:26-34. [PMID: 24131472 DOI: 10.1111/cas.12304] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
44 Liu K, Feng F, Chen XZ, Zhou XY, Zhang JY, Chen XL, Zhang WH, Yang K, Zhang B, Zhang HW, Zhou ZG, Hu JK. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China. Gastric Cancer 2019;22:506-17. [PMID: 30390154 DOI: 10.1007/s10120-018-0890-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
45 Lu J, Zheng CH, Cao LL, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Huang CM. Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer. Oncotarget 2017;8:83555-62. [PMID: 29137363 DOI: 10.18632/oncotarget.18375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
46 Kwon OK, Kim SW, Chae HD, Ryu SW, Chung HY, Kim SW, Lee WK, Yu W. Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study. Ann Surg Treat Res 2016;91:295-302. [PMID: 27904851 DOI: 10.4174/astr.2016.91.6.295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]